HomeCSWYY • OTCMKTS
add
China Shineway Pharmaceutical Group ADR
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 845.67M | -20.14% |
Operating expense | 492.07M | -18.40% |
Net income | 106.79M | -55.32% |
Net profit margin | 12.63 | -44.04% |
Earnings per share | — | — |
EBITDA | 179.18M | -22.75% |
Effective tax rate | 24.70% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.49B | 9.76% |
Total assets | 10.04B | 4.88% |
Total liabilities | 2.57B | 1.39% |
Total equity | 7.47B | — |
Shares outstanding | 755.40M | — |
Price to book | 1.88 | — |
Return on assets | 3.43% | — |
Return on capital | 4.41% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 106.79M | -55.32% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2002
Website
Employees
3,232
